Enfeng Wang

4.8k total citations
84 papers, 3.8k citations indexed

About

Enfeng Wang is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Enfeng Wang has authored 84 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 20 papers in Oncology and 14 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Enfeng Wang's work include Angiogenesis and VEGF in Cancer (21 papers), Cancer, Hypoxia, and Metabolism (10 papers) and Advanced MRI Techniques and Applications (10 papers). Enfeng Wang is often cited by papers focused on Angiogenesis and VEGF in Cancer (21 papers), Cancer, Hypoxia, and Metabolism (10 papers) and Advanced MRI Techniques and Applications (10 papers). Enfeng Wang collaborates with scholars based in United States, China and India. Enfeng Wang's co-authors include Debabrata Mukhopadhyay, Resham Bhattacharya, Phillip Zhe Sun, Jerry S. Cheung, Shamit K. Dutta, Priyabrata Mukherjee, Krishnendu Pal, Kaustubh Datta, Rochelle R. Arvizo and Eng H. Lo and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Enfeng Wang

83 papers receiving 3.7k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Enfeng Wang	1.6k	798	764	661	632	84	3.8k
John W. Chen	2.2k 1.3×	397 0.5×	473 0.6×	551 0.8×	737 1.2×	98	6.1k
Yun‐Sang Lee	957 0.6×	296 0.4×	1.3k 1.7×	413 0.6×	472 0.7×	166	3.4k
Jeeva Munasinghe	1.1k 0.7×	632 0.8×	620 0.8×	293 0.4×	516 0.8×	72	3.4k
Dong‐Eog Kim	1.2k 0.8×	245 0.3×	432 0.6×	216 0.3×	350 0.6×	117	4.5k
Bertrand Tavitian	2.5k 1.5×	202 0.3×	1.3k 1.6×	667 1.0×	355 0.6×	153	5.4k
Henry F. VanBrocklin	888 0.5×	224 0.3×	1.2k 1.6×	636 1.0×	365 0.6×	155	3.4k
Michael Schirner	1.6k 1.0×	178 0.2×	670 0.9×	1.0k 1.5×	454 0.7×	101	4.2k
Yasuhisa Fujibayashi	1.5k 0.9×	580 0.7×	3.7k 4.8×	1.1k 1.6×	1.5k 2.4×	237	7.3k
Michelle L. James	1.2k 0.7×	239 0.3×	754 1.0×	493 0.7×	194 0.3×	66	3.7k
Gregory R. Wojtkiewicz	1.8k 1.1×	556 0.7×	505 0.7×	628 1.0×	282 0.4×	79	5.6k

Countries citing papers authored by Enfeng Wang

Since Specialization

Citations

This map shows the geographic impact of Enfeng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enfeng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enfeng Wang more than expected).

Fields of papers citing papers by Enfeng Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enfeng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enfeng Wang. The network helps show where Enfeng Wang may publish in the future.

Co-authorship network of co-authors of Enfeng Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Enfeng Wang. A scholar is included among the top collaborators of Enfeng Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enfeng Wang. Enfeng Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Angom, Ramcharan Singh, Shamit K. Dutta, Enfeng Wang, et al.. (2024). Dual drug-loaded tumor-targeted polymeric nanoparticles for enhancing therapeutic response in pancreatic ductal adenocarcinoma. Materials Today Bio. 28. 101199–101199. 10 indexed citations

Angom, Ramcharan Singh, Ying Wang, Enfeng Wang, Shamit K. Dutta, & Debabrata Mukhopadhyay. (2023). Conditional, Tissue-Specific CRISPR/Cas9 Vector System in Zebrafish Reveals the Role of Nrp1b in Heart Regeneration. Arteriosclerosis Thrombosis and Vascular Biology. 43(10). 1921–1934. 4 indexed citations

Angom, Ramcharan Singh, Jian Zhu, Alexander T.H. Wu, et al.. (2021). LCC-09, a Novel Salicylanilide Derivative, Exerts Anti-Inflammatory Effect in Vascular Endothelial Cells. Journal of Inflammation Research. Volume 14. 4551–4565. 3 indexed citations

Madamsetty, Vijay Sagar, Ramcharan Singh Angom, Shamit K. Dutta, et al.. (2021). Role of PLEXIND1/TGFβ Signaling Axis in Pancreatic Ductal Adenocarcinoma Progression Correlates with the Mutational Status of KRAS. Cancers. 13(16). 4048–4048. 6 indexed citations

Rachamalla, Hari Krishnareddy, Santanu Bhattacharya, Ajaz Ahmad, et al.. (2021). Enriched Pharmacokinetic Behavior and Antitumor Efficacy of Thymoquinone by Liposomal Delivery. Nanomedicine. 16(8). 641–656. 4 indexed citations

Madamsetty, Vijay Sagar, Krishnendu Pal, Shamit K. Dutta, Enfeng Wang, & Debabrata Mukhopadhyay. (2020). Targeted Dual Intervention-Oriented Drug-Encapsulated (DIODE) Nanoformulations for Improved Treatment of Pancreatic Cancer. Cancers. 12(5). 1189–1189. 8 indexed citations

Bhattacharya, Santanu, Xun Gong, Enfeng Wang, et al.. (2019). DNA–SWCNT Biosensors Allow Real-Time Monitoring of Therapeutic Responses in Pancreatic Ductal Adenocarcinoma. Cancer Research. 79(17). 4515–4523. 20 indexed citations

Madamsetty, Vijay Sagar, Krishnendu Pal, Shamit K. Dutta, et al.. (2019). Design and Evaluation of PEGylated Liposomal Formulation of a Novel Multikinase Inhibitor for Enhanced Chemosensitivity and Inhibition of Metastatic Pancreatic Ductal Adenocarcinoma. Bioconjugate Chemistry. 30(10). 2703–2713. 16 indexed citations

Madamsetty, Vijay Sagar, Krishnendu Pal, Sandeep Keshavan, et al.. (2019). Development of multi-drug loaded PEGylated nanodiamonds to inhibit tumor growth and metastasis in genetically engineered mouse models of pancreatic cancer. Nanoscale. 11(45). 22006–22018. 48 indexed citations

10.

Wang, Ying, Luke H. Hoeppner, Ramcharan Singh Angom, et al.. (2019). Protein kinase D up-regulates transcription of VEGF receptor-2 in endothelial cells by suppressing nuclear localization of the transcription factor AP2β. Journal of Biological Chemistry. 294(43). 15759–15767. 9 indexed citations

11.

Pal, Krishnendu, Vijay Sagar Madamsetty, Shamit K. Dutta, et al.. (2019). Synchronous inhibition of mTOR and VEGF/NRP1 axis impedes tumor growth and metastasis in renal cancer. npj Precision Oncology. 3(1). 31–31. 37 indexed citations

12.

Pal, Krishnendu, Roberto González-Rodríguez, Shamit K. Dutta, et al.. (2017). Multifaceted peptide assisted one-pot synthesis of gold nanoparticles for plectin-1 targeted gemcitabine delivery in pancreatic cancer. Nanoscale. 9(40). 15622–15634. 52 indexed citations

13.

Pal, Krishnendu, Alexandre A. Pletnev, Shamit K. Dutta, et al.. (2014). Inhibition of Endoglin–GIPC Interaction Inhibits Pancreatic Cancer Cell Growth. Molecular Cancer Therapeutics. 13(10). 2264–2275. 17 indexed citations

14.

Pal, Krishnendu, Ying Cao, Irina N. Gaisina, et al.. (2013). Inhibition of GSK-3 Induces Differentiation and Impaired Glucose Metabolism in Renal Cancer. Molecular Cancer Therapeutics. 13(2). 285–296. 57 indexed citations

15.

Cao, Ying, Luke H. Hoeppner, Yan Guo, et al.. (2013). Neuropilin-2 Promotes Extravasation and Metastasis by Interacting with Endothelial α5 Integrin. Cancer Research. 73(14). 4579–4590. 86 indexed citations

16.

Cao, Ying, Enfeng Wang, Krishnendu Pal, et al.. (2012). VEGF Exerts an Angiogenesis-Independent Function in Cancer Cells to Promote Their Malignant Progression. Cancer Research. 72(16). 3912–3918. 116 indexed citations

17.

Sinha, Sutapa, Bathula Surendar Reddy, Krishnendu Pal, et al.. (2011). A Lipid-Modified Estrogen Derivative that Treats Breast Cancer Independent of Estrogen Receptor Expression through Simultaneous Induction of Autophagy and Apoptosis. Molecular Cancer Research. 9(3). 364–374. 38 indexed citations

18.

Bhattacharya, Resham, Milena S. Nicoloso, Rochelle R. Arvizo, et al.. (2009). MiR-15a and MiR-16 Control Bmi-1 Expression in Ovarian Cancer. Cancer Research. 69(23). 9090–9095. 206 indexed citations

19.

Muders, Michael H., Heyu Zhang, Enfeng Wang, Donald J. Tindall, & Kaustubh Datta. (2009). Vascular Endothelial Growth Factor-C Protects Prostate Cancer Cells from Oxidative Stress by the Activation of Mammalian Target of Rapamycin Complex-2 and AKT-1. Cancer Research. 69(15). 6042–6048. 54 indexed citations

20.

Patra, Chitta Ranjan, Resham Bhattacharya, Enfeng Wang, et al.. (2008). Targeted Delivery of Gemcitabine to Pancreatic Adenocarcinoma Using Cetuximab as a Targeting Agent. Cancer Research. 68(6). 1970–1978. 296 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact